March 30, 2015

Experimental Ebola Vaccines Appear Safe in Phase 2 Liberian Clinical Trial

No comments:
Liberia–U.S. partnership planning Phase 3 trial and study of Ebola survivors

Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase 2/3 clinical trial, according to interim findings from an independent Data and Safety Monitoring Board review.

March 28, 2015

Sun Pharma Concludes Take Over Merger Of Ranbaxy Laboratories

No comments:
SUN PHARMA CLOSE RANBAXY MERGER DEAL

Sun Pharmaceutical Industries Limited, the multinational pharmaceutical company headquartered in Mumbai, Maharashtra, few days ago on Wednesday announced the take over and closure of its merger with Ranbaxy Laboratories.

March 27, 2015

Simply Breaking Up Sitting Time Shows Demonstrable Health Benefits In Type 2 Diabetes

No comments:
EVEN INTERRUPTING SITTING TIME IMPROVES HEALTH IN TYPE 2 DM

People with Type 2 diabetes could trim down and improve their metabolic health by replacing long periods of sitting with periodic standing, taking the stairs or even just changing the television station manually, according to a new study, “The Potential Impact of Displacing Sedentary Time in Adults with Type 2 Diabetes.”